[1] Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis[J]. Lancet,2017,389:1756-1770. [2] 甄建华,黄光瑞.溃疡性结肠炎病因和发病机制的现代医学研究进展[J]. 世界华人消化杂志,2019,27:245-251. [3] 倪杰明,刘维新.肠黏膜屏障损伤在溃疡性结肠炎的作用研究进展[J]. 安徽医科大学学报,2018,53:815-818. [4] Lameris AL, Huybers S, Kaukinen K, et al. Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease[J]. Scand J Gastroenterol,2013,48:58-69. [5] Lu Z, Ding L, Lu Q, et al. Claudins in intestines: Distribution and functional significance in health and diseases[J]. Tissue Barriers, 2013,1:e24978. doi: 10.4161/tisb.24978. [6] 张冬妮,王忆安,李广文, 等. 帕金森病模型大鼠十二指肠黏膜紧密连接蛋白表达下调[J]. 基础医学与临床,2017,37:1359-1362. [7] Emami CN, Chokshi N, Wang J, et al. Role of interleukin-10 in the pathogenesis of necrotizing entero-colitis[J]. Am J Surg,2012,203:428-435. [8] Mizoguchi A, Yano A, Himuro H, et al. Clinical importance of IL-22 cascade in IBD[J]. J Gastroenterol, 2018,53:465-474. [9] Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines-from host defence to tissue homeostasis[J]. Nat Rev Immunol, 2014,14:783-795. [10] Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system[J]. Nat Rev Drug Discov,2014,13:21-38. [11] 李茹柳, 迟莉, 郭文峰, 等. 紧密连接蛋白occludin和claudin-1在大鼠溃疡性结肠炎的表达[J]. 广州中医药大学学报, 2008, 25:83-87,90. [12] Ashizuka S, Inagaki-Ohara K, Kuwasako K, et al. Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium[J]. Microbiol Immunol,2009,53: 573-581. [13] Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease[J]. Cytokine Growth Factor Rev,2010, 21:435-441. [14] 成海燕,张亚姝,迟宏罡.IL-22及肠道干细胞在肠黏膜屏障中的作用[J]. 广东医学,2016,37:3133-3135. |